✨ Medicines Consent Notices




3616 NEW ZEALAND GAZETTE No. 114

Renewal of Provisional Consent to the Distribution of New Medicines

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Paclitaxel 6 mg/mL in 5 mL, 16.7 mL, 25 mL Concentrate for infusion Bristol-Caribbean Inc., Mayaguez, Puerto Rico Taxol

Note:

  1. This medicine may only be distributed, supplied, or used under conditions to be imposed from time to time by the Director-General of Health.

  2. This consent is effective from 29 July 1995.

Dated this 4th day of October 1995.

KAREN O. POUTASI, Director-General of Health, pursuant to delegation given by the Minister of Health on 25 June 1993.


go6736

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Sodium Bicarbonate 100% w/w (700 g) Powder (sachet) Mainland Pharmazeutische Fabrik, Frankfurt, Germany Bi-Caps
Clotrimazole Cream Bayer AG, Leverkusen, Germany Canesten HC
150 mg/hydrocortisone, 150 mg (1%) clotrimazole in 15 g,
300 mg/hydrocortisone, 300 mg (1%) clotrimazole in 30 g
Influenza virus A/Beijing/32/92 15.0 mcg, influenza virus A/Texas/36/91 15.0 mcg, Suspension for injection Evans Medical Limited, Speke, Liverpool, England Fluvirin Inactivated Influenza
influenza virus B/Panama/45/90 15.0 mcg in 0.5 mL (pre-filled syringe) Vaccine
Opium tincture 0.0838 mL, squill oxymel 1.67 mL in 5 mL Syrup Douglas Pharmaceuticals Limited, Mount Wellington, Auckland Gee’s Linctus
Oestradiol delivery rate: 37.5 mcg/day, 50 mcg/day, 75 mcg/day, 100 mcg/day Transdermal patch Noven Pharmaceuticals Inc., Miami, Florida, United States of America Menorest
Note: Not to be marketed as substitutable for any other oestradiol transdermal patch as if the two (2) products were bioequivalent.
Carbomer 940 2 mg/g, cetrimide 0.1 mg/g Gel, ophthalmic Ciba Vision AG., Hettlingen, Switzerland and Dr Mann Pharma Chem-Pharm Fabrik GmbH., Berlin, Germany Viscotears Liquid Gel

Dated this 5th day of October 1995.

KAREN O. POUTASI, Director-General of Health, pursuant to delegation given by the Minister of Health on 25 June 1993.


go6737



Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa PDF NZ Gazette 1995, No 114


NZLII PDF NZ Gazette 1995, No 114





✨ LLM interpretation of page content

πŸ₯ Renewal of Provisional Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
4 October 1995
Medicines Act, Provisional Consent, Paclitaxel, Taxol, Distribution
  • KAREN O. POUTASI, Director-General of Health

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
5 October 1995
Medicines Act, Consent, Sodium Bicarbonate, Clotrimazole, Influenza Vaccine, Opium Tincture, Oestradiol Patch, Carbomer Gel
  • KAREN O. POUTASI, Director-General of Health